Alector develops therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's. It last closed at $2.56 on Nov 17, down 0.39% on the day. The average 12-month price target from 2 analysts is $5.50 (+114.8% from the last close), with a high of $8.00 and a low of $3.00. In the past 30 days there were 2 dark pool prints totaling $281K, the largest $175K.
Only 2 firms rated ALEC in the past 90 days, not enough for a consensus
Average 12-month target
$5.50
▲ 114.8% upside
Based on 2 analysts who set a price target on ALEC in the past 90 days. The average target is $5.50, with a high of $8.00 and a low of $3.00, compared with the last close of $2.56.
Low $3.00Avg $5.50High $8.00
Blue marker: last close $2.56
Highest target$8.00
Average target$5.50
Lowest target$3.00
Latest rating changes
HC Wainwright & Co.Maintained
Oct 14Buy$8
Morgan StanleyMaintained
Oct 6Sell$3
Date
Firm
Action
Rating
Price target
Oct 14
HC Wainwright & Co.
Maintained
Buy
$8
Oct 6
Morgan Stanley
Maintained
Sell
$3
Loading…
Technical Analysis
ALEC · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought
The stock is 13% above its 20 day and 19% above its 50 day average. It is 20% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 62), near overbought. The nearest support is the Pivot S1 at $2.50, and the nearest resistance the Pivot R1 at $2.61.
Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityNormal, 8.2%/day
Key levels
$2.8452 week high+10.9%
$2.73Swing high (Oct 5)+6.6%
$2.61Pivot R1+2.0%
$2.56Pivot+0.0%
$2.56Last close
$2.50Pivot S1−2.3%
$2.2420 day average−12.5%
$2.22Swing low (Sep 1)−13.3%
$2.0750 day average−19.1%
$2.06200 day average−19.5%
$1.99100 day average−22.3%
$1.0952 week low−57.4%
Indicators
RSI (14)
62.34
Strong, overbought above 70
Neutral
MACD
0.15
Above its signal line
Bullish
Stochastic
67.7
Middle of its range
Neutral
ADX (14)
28.0
Trending up
Williams %R
-34.4
Oversold below −80, overbought above −20
Neutral
CCI (20)
101.3
Oversold below −100, overbought above 100
Overbought
Rate of change
+24.9%
Change over 10 sessions
Bullish
ATR (14)
$0.21
Typical daily range, 8.3% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Bounce inside a longer downtrend
Short trendBullish
Long trendBearish
MomentumStrong
StretchNormal
VolatilityHigh, 15.9%/day
Key levels
$2.8452 week high+10.9%
$2.73Swing high (Oct 5)+6.6%
$2.61Pivot R1+2.0%
$2.56Pivot+0.0%
$2.56Last close
$2.50Pivot S1−2.3%
$2.2420 day average−12.5%
$2.22Swing low (Sep 1)−13.3%
$2.0750 day average−19.1%
$2.06200 day average−19.5%
$1.99100 day average−22.3%
$1.0952 week low−57.4%
Indicators
RSI (14)
60.73
Strong, overbought above 70
Neutral
MACD
0.10
Above its signal line
Bullish
Stochastic
71.5
Middle of its range
Neutral
ADX (14)
31.1
Trending up
Williams %R
-25.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
131.8
Oversold below −100, overbought above 100
Overbought
Rate of change
+19.6%
Change over 10 sessions
Bullish
ATR (14)
$0.41
Typical daily range, 15.9% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Below
What happened before, for ALEC
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ALEC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow ALEC usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How ALEC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ALEC is in one of them and how their past ALEC trades turned out.
Alector is a biotechnology company that develops treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's. Its drug candidates aim to remove harmful proteins, replace missing ones, or restore normal cell function. The company also builds a proprietary technology designed to help drugs reach the brain, and it partners with drugmakers such as GSK on some programs. Based in South San Francisco, California, Alector is still testing its candidates in clinical studies.